Status:
RECRUITING
Appropriateness of Angioplasty in Patients With Chronic Coronary Syndromes
Lead Sponsor:
University of Sao Paulo General Hospital
Collaborating Sponsors:
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Conditions:
Coronary Artery Disease
Angina Pectoris
Eligibility:
All Genders
18+ years
Brief Summary
Percutaneous coronary intervention (PCI) has dramatically changed the treatment of obstructive coronary artery disease patients. PCI is indicated in patients with chronic coronary syndrome (CCS) sympt...
Detailed Description
Percutaneous coronary intervention (PCI) has dramatically changed the treatment of obstructive coronary artery disease patients. PCI is indicated in patients with chronic coronary syndrome (CCS) sympt...
Eligibility Criteria
Inclusion
- All patients within the age range who underwent elective PCI defined as a procedure indicated in an outpatient scenario or an inpatient in a non-acute setting when the Heart Team was called to evaluate the patient and agreed with the indication for PCI
Exclusion
- History of acute coronary syndrome \< 30 days of the referral for PCI
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
1875 Patients enrolled
Trial Details
Trial ID
NCT06545448
Start Date
December 1 2017
End Date
December 31 2025
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Institute (InCor-HCFMUSP)
São Paulo, São Paulo, Brazil, 05403000